Caballero, Marta
Sabate, Antoni
Perez, Lourdes
Vidal, Julia
Reverter, Enric
Gutierrez, Rosa
Crespo, Gonzalo
Penafiel, Judith
Blasi, Annabel
Funding for this research was provided by:
Instituto de Salud Carlos III (the project PI17/00743, the project PI17/00743, the project PI17/00743, the project PI17/00743, the project PI17/00743)
the Spanish Clinical Research Network-UICEC (SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027, SCReN PT17/0017/0010, PT20/000008, State Plan 2020-2017 and EECTI 2021-2027)
CERCA Programme of the Autonomous Government of Catalonia
Article History
Received: 31 July 2023
Accepted: 24 October 2023
First Online: 2 November 2023
Declarations
:
: The protocol was approved by the institutional review board (IRB) of the lead hospital (University Hospital of Bellvitge, approval number AC 033/18) as well as the IRBs of the other participating centres (University Hospital of Cruces and Clinic Hospital of Barcelona). Patients were enrolled if they gave their written informed consent.
: The manuscript does not contain any individual data.
: The authors declare no competing interests.